Company intelligence / Profile preview
Curative Biotechnology, Inc.
Palm Beach Gardens, Florida, United Statescurativebiotech.com ↗
- Ownership
- Public · CUBT
- Employees
- ~4
- Development stage
- Preclinical
01
Overview
Curative Biotechnology has completed IND-enabling studies for its metformin eye drop formulation targeting AMD. The company is preparing for first-in-human clinical trials in collaboration with the National Eye Institute. Other programs are at preclinical or early clinical stages.[5][9]
- Therapeutic areas
- OphthalmologyOncologyInfectious Diseases
- Modalities
- Small molecules (e.g., metformin reformulation)Monoclonal antibodies (e.g., CD56 mAb ADC)Immunotherapies/adjuvants (e.g., IMT504)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Mid‐Atlantic BioTherapeutics, Inc. — licensing/co-development of IMT504 for rabies/COVID vaccine adjuvant use[1][3].
04
Financials
- Market cap
- $4.8M
- Total revenue
- $0
- Enterprise value
- $6M
Beyond the preview
Go deeper on Curative Biotechnology, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Curative Biotechnology, Inc..